NSAIDs and Tissue Healing — Help or Hinder?

The VerdictMODERATE CONVICTIONVerdict Score 65

The same drug that cuts your muscle gains in half at 30 can improve them at 65 — but it can double your fracture risk in either.

Tonight, check your medicine cabinet. If you're taking ibuprofen regularly around training sessions or after an injury — what tissue is actually injured? The answer changes everything.

What this actually is: NSAIDs block a chemical called PGE2 — the exact signal your muscle stem cells need to grow — cutting strength and muscle gains by roughly 50% in young adults over 8 weeks (Lilja 2018, RCT).
The myth that won't die: "Take ibuprofen to recover faster from training" is the most common advice that directly undoes what the session created.
Start here: If you're under 60 and training to build strength, stop scheduled NSAID use around training. Paracetamol works just as well for pain relief without touching your muscle adaptations.

Think of PGE2 — the molecule NSAIDs block — as the emergency text your body sends to muscle stem cells after a hard session: "Wake up, divide, repair the damage." In a 30-year-old, blocking that text is like turning off your alarm clock on game day. In a 70-year-old whose body is already sending thousands of background noise signals due to chronic low-grade inflammation, muting some of that noise can actually let the real signal get through — which is why the same drug does opposite things depending on your age.

Tonight, check if you're taking ibuprofen regularly around training sessions or after an injury.

If you are — the tissue type determines whether it's helping your recovery or quietly working against it. Paracetamol is as effective for pain in most soft tissue injuries, without the trade-offs.

Takes 2 minutes. No equipment. Just awareness.

The Verdict

The same drug that cuts your muscle gains in half at 30 can improve them at 65 — but it can also double your fracture healing risk in either.

Think of PGE2 — the molecule NSAIDs block — as the emergency text your body sends to muscle stem cells after a hard session: "Wake up, divide, repair the damage." In a 30-year-old, blocking that text is like turning off your alarm clock on game day. In a 70-year-old whose body is constantly sending thousands of background-noise signals due to chronic low-grade inflammation, muting some of that noise can actually let the real signal get through. Same drug, opposite effect — because the context is completely different.

What this actually is: NSAIDs block the exact chemical signal your muscle stem cells need to grow — in young adults, a normal dose cuts strength and muscle gains by roughly 50% over 8 weeks (Lilja 2018, RCT).
The myth that won't die: "Take ibuprofen to recover faster from training" is among the most common fitness advice — and it directly undoes what the session was designed to create.
Start here: If you're under 60 and training for muscle or strength, stop any scheduled or pre-training NSAID use. Paracetamol handles the pain without touching your adaptations.

Want the full evidence breakdown? Keep scrolling

What's Actually Going On

The COX-2 / PGE2 Pathway

When tissue is damaged — a muscle tear, a bone stress injury, an inflamed tendon — your body triggers a cascade. Phospholipase A2 releases arachidonic acid. COX-2 (an enzyme your body switches on during injury) converts it into Prostaglandin E2 (PGE2). That's the molecule doing the heavy lifting.

NSAIDs block COX-2. That shuts down PGE2 production at the injury site. The problem: PGE2 doesn't just cause inflammation — it runs most of the repair programme.

Bone

PGE2 drives mesenchymal stem cells to become osteoblasts. Without it, callus formation stalls. Adult non-union risk nearly doubles (OR 1.98, Chuang 2024).

Tendon-to-Bone

Tendon repairs anchor via Sharpey's fibers — osteoblast-dependent. COX-2 inhibitors (like Celebrex) directly increase retear rates post-surgery (Oh 2018).

Muscle (Young Adults)

PGE2 binds EP4 receptors on satellite cells (muscle stem cells), triggering the Nurr1 pathway for cell division. Block PGE2, block the stem cell signal. ~50% blunting in 8 weeks.

Muscle (65+ Adults)

Inflammaging creates persistent background cytokine noise that suppresses muscle protein synthesis. NSAIDs quiet that background signal, paradoxically improving training adaptation.

Ligament

Alternative repair pathways exist. Animal models show transient tensile strength loss, but human clinical data shows no meaningful increase in ligament failure rates.

The "Inflammaging" Paradox

Adults 65+ often have chronically elevated TNF-α, IL-6, and CRP — a state called inflammaging. This chronic background inflammation suppresses muscle protein synthesis independently of any injury. In this context, NSAIDs work differently: they reduce the chronic noise rather than silencing a critical repair signal. The 2025 mechanistic update (Wang et al., Cell Stem Cell) reveals the underlying biology: aged muscle stem cells are actually starved of local PGE2, not flooded with it. The future treatment may eventually be EP4 agonism — delivering PGE2 locally — rather than systemic NSAID inhibition. But that's not available yet.

Clinical Decision Framework

When to Use, When to Avoid

No dedicated clinical practice guideline exists for NSAID use in MSK rehabilitation as of 2026. The evidence below is extrapolated from surgical literature, pharmacology RCTs, and meta-analyses.

Clinical Scenario	Short-Term (<2 weeks)	Chronic (>2 weeks)	Verdict
Adult bone stress injury / fracture	CAUTION	AVOID	AVOID — doubles non-union risk
Post-op tendon-to-bone repair	Caution (non-selective only)	AVOID	AVOID COX-2 — retear risk
Reactive / acute tendinopathy	Acceptable (max 7 days)	CAUTION	SHORT COURSE OK — analgesia to enable loading
Degenerative / chronic tendinopathy	CAUTION (pain masking only)	AVOID	AVOID LONG-TERM — treat load tolerance, not pain
Muscle EIMD — young adults (<60)	CAUTION	AVOID	DISCOURAGE — blunts 50% of hypertrophy
Muscle EIMD — adults 65+ in RT program	RECOMMEND	RECOMMEND (GP oversight)	MAY ENHANCE — reverses inflammaging suppression
Acute ligament sprain	SAFE / NEUTRAL	CAUTION	PREFER PARACETAMOL — equivalent efficacy, fewer risks
Post-op spinal fusion	CAUTION	AVOID	AVOID — bone graft non-union risk

Evidence levels: Bone (Tier 3, Chuang 2024, Schug 2021) | Tendon (Tier 4, Oh 2018) | Muscle (Tier 4, Lilja 2018, Trappe 2011) | Ligament (Tier 2 Cochrane, Jones 2020)

Red Flags

When NSAIDs Are Contraindicated

⚠ Refer / Advise Against

Adult bone stress injury or conservatively managed fracture — NSAIDs impair callus formation. OR 1.98 for adult non-union (Chuang 2024 meta N=523,240). ABSOLUTE CLINICAL CONTRAINDICATION.
Post-operative tendon-to-bone repair (rotator cuff, ACL graft) — COX-2 selective inhibitors significantly increase retear rates at 24 months (Oh 2018, RCT). Avoid celecoxib/Celebrex. Short-term non-selective may be acceptable for severe acute pain.
Post-operative spinal fusion — COX-2 inhibitors significantly increase non-union rates; avoid (Dahners 2004).
Young athlete in active hypertrophy/strength phase (<35) — High-dose ibuprofen (1200mg/day) cuts adaptation gains ~50%. Urgent education and discontinuation.
History of GI ulcers / renal disease — Standard pharmacological contraindications apply regardless of MSK context. Refer to GP.

The Debate

Older Advice vs Recent Evidence

Prophylactic NSAID Use in Athletes

Conventional practice / fitness culture

"Take ibuprofen before or after training to reduce soreness and recover faster."

Lilja et al., 2018, Acta Physiol (RCT)

Ibuprofen 1200mg/day vs low-dose aspirin for 8 weeks: blunted strength and hypertrophy ~50% via PGE2/EP4/satellite cell arrest.

Clinical implication: Prophylactic NSAID use in young athletes is not just unhelpful — it actively opposes the training goal. Follow the 2018 RCT evidence.

NSAIDs After Rotator Cuff Repair

Standard perioperative care (pre-2018)

"NSAIDs acceptable for opioid-sparing post-operative pain management after tendon repair."

Oh et al., 2018, Am J Sports Med (RCT)

Celecoxib (COX-2 selective) produced significantly higher retear rates at 24 months vs ibuprofen (non-selective) or tramadol.

Clinical implication: The distinction between COX-2 selective and non-selective NSAIDs is clinically significant at the tendon-to-bone interface. COX-2 inhibitors are contraindicated; non-selective may be acceptable short-term.

NSAIDs in the Elderly

General prescribing caution (standard)

"Avoid NSAIDs in elderly patients — cardiovascular, GI, and renal risk profile."

Trappe et al., 2011, Am J Physiol (clinical trial)

Ibuprofen 1200mg/day enhanced muscle protein synthesis and hypertrophy in older adults via inflammaging reversal.

Clinical implication: Risk-benefit calculation shifts for 65+ adults in resistance training programs. Moderate-term NSAID use may improve training outcomes — but systemic risk assessment and GP oversight remain mandatory.

Honest Limitations

Where the Research Falls Short

Limitation 1: Animal Dose Equivalency

The Research Finding

Many foundational NSAID-healing studies used rodent models with doses that, when allometrically scaled, represent severe overdoses relative to human therapeutic levels.

The Real-World Gap

Clinicians sometimes cite this animal harm data to patients without recognising the dose is 5-10× a standard human prescription. This overcalibrates fear for soft tissue injuries where short-term human data shows minimal risk.

Clinical Adjustment

Anchor advice on human RCT data (Lilja 2018, Oh 2018) where standard OTC doses were used. The harm is real but proportionate — not catastrophic for soft tissue injuries.

Limitation 2: The Safe Short-Term Window

The Research Finding

Orthopedic surgical reviews (Schug 2021) consistently show ≤7-14 days post-operative NSAID use does not cause clinically significant long-term healing impairment.

The Real-World Gap

Patients and athletes routinely self-medicate for 4-8 weeks continuously. The harm data is almost entirely duration-dependent — the "safe window" concept is rarely communicated in practice.

Clinical Adjustment

Establish explicit duration limits at every NSAIDrecommendation: maximum 7 days for soft tissue, STOP regardless of remaining pain. If pain persists beyond 7 days, reassess the diagnosis, don't extend the NSAID.

Limitation 3: Population Mismatch

The Research Finding

The strongest human clinical data comes from highly controlled post-surgical populations: spinal fusion, rotator cuff repair, ACL reconstruction.

The Real-World Gap

The typical MSK physiotherapy caseload — tendinopathy, bone stress injuries, gym-related overuse — lacks direct clinical trial data. Clinicians extrapolate from surgical data without flagging the gap.

Clinical Adjustment

Apply surgical harm data conservatively to non-surgical presentations. For bone stress injuries, the callus formation mechanism applies regardless of surgery. For muscle, the non-surgical RCT data (Lilja 2018) is directly applicable.

What Works

Evidence-Based Recommendations

Tier 1 — Strong Evidence

Paracetamol for acute soft tissue injuries STRONG

Cochrane Review (Jones 2020, 20 RCTs, N=3305): equivalent pain relief to NSAIDs at 1-7 days for ligament sprains, with fewer GI adverse events. Should be the default first-line analgesic for most MSK presentations.

AVOID NSAIDs in adult bone stress injuries STRONG

Meta-analysis N=523,240 (Chuang 2024): adult NSAID exposure nearly doubles crude non-union risk (OR 1.98). COX-2 pathway directly governs endochondral ossification. Paracetamol + pain-guided progressive loading is the correct pathway.

AVOID COX-2 inhibitors post-tendon-to-bone repair STRONG

RCT (Oh 2018): celecoxib vs ibuprofen vs tramadol post-rotator cuff repair — celecoxib group had significantly higher retear rates at 24 months. Non-selective NSAIDs (ibuprofen) acceptable short-term if required for severe pain; COX-2 selective inhibitors are contraindicated.

See Tier 2 and Tier 3 recommendations

Tier 2 — Moderate Evidence

Short-term non-selective NSAIDs for acute reactive tendinopathy MODERATE

Provides analgesia to enable essential mechanical loading — the actual treatment. Maximum 7 days. Does not address underlying load-tolerance deficit. Transition to progressive loading immediately.

NSAIDs for 65+ adults in resistance training programs MODERATE

Clinical trial (Trappe 2011): ibuprofen 1200mg/day enhanced muscle protein synthesis and hypertrophy in older adults. Inflammaging reversal appears to outweigh local PGE2 suppression. Systemic risk profile assessment and GP oversight mandatory for ongoing use.

Tier 3 — Emerging / Contextual

EP4 Receptor Agonism (Future) EMERGING

Wang et al. 2025 (Cell Stem Cell): aged muscle stem cells are actually PGE2-depleted, not PGE2-flooded. Localized EP4 agonism may eventually replace systemic NSAIDs for rehabilitation in older adults. No clinical therapy available yet.

What Doesn't Work (Despite Common Practice)

Prophylactic ibuprofen before training sessions — directly blunts the molecular adaptations the session creates. No scientific justification. Cultural practice with active harms.
Long-term NSAIDs for degenerative tendinopathy — degenerative tendinopathy has minimal active inflammation; NSAIDs mask pain without treating the load-tolerance deficit. Creates diagnostic masking risk for worsening pathology.
NSAIDs as the default "first-line" for all MSK injuries — paracetamol is equivalent for pain in most soft tissue presentations with a better safety profile. The "default NSAID" approach ignores tissue specificity.

Practical Guidance

NSAID Duration Rules by Tissue

Soft Tissue Sprain

Max 5-7 days

NSAIDs acceptable if GI history clear. Paracetamol preferred. Stop after 7 days regardless of pain level — reassess the injury if pain persists.

Reactive Tendinopathy

Max 5-7 days

Short course to enable loading. Transition to exercise-based management immediately. Don't use NSAIDs as a substitute for the loading programme.

Bone Stress Injury

AVOID

DO NOT USE

Paracetamol only. NSAIDs impair bone callus formation regardless of injury severity or duration of use.

Young Athlete in Training

NO SCHEDULED USE

Discontinue prophylactic and scheduled use immediately. Single-dose for acute injury pain only if needed. Paracetamol for DOMS management.

Adults 65+ in RT Program

BENEFICIAL

Standard ibuprofen may enhance training adaptations. Monitor systemic risk factors (BP, renal function). GP involvement for ongoing use beyond 2 weeks.

Post-Surgical Tendon

AVOID COX-2

Celecoxib/Celebrex contraindicated after tendon-to-bone repairs. Non-selective ibuprofen acceptable short-term if opioid-sparing required. Always confirm with surgeon.

Return-to-Training Criteria

NSAID Weaning Criteria

Underlying injury identified and managed with condition-specific protocol
NSAID duration not exceeding tissue-specific safe window (≤7 days for soft tissue)
Transition from NSAID to paracetamol completed at or before day 7 for soft tissue presentations
No scheduled NSAID use in the 24 hours before or after resistance training sessions (athletes <60)
Post-operative patients: cleared by surgeon before any NSAID use
65+ patients: GP-reviewed systemic risk profile if continuing NSAID use beyond 2 weeks

The Nuance

What the Simple Answer Misses

Animal vs Human Evidence Gap

Much of the fear around NSAIDs in tissue healing originates from animal studies using doses equivalent to 5-10× the human therapeutic range. The biological mechanism (PGE2 suppression) is real and conserved in humans — but the severity is exaggerated by the translation. For soft tissue injuries, short-term human data is far more reassuring than the animal literature suggests.

COX-2 Selectivity Is the Critical Variable for Tendon

The phrase "NSAIDs are harmful after rotator cuff surgery" is imprecise. The 2018 RCT (Oh) specifically showed celecoxib — a COX-2 selective inhibitor — increased retear risk. Ibuprofen (non-selective) and tramadol showed no equivalent harm. If someone insists on NSAID analgesia post-tendon repair, choosing a non-selective agent matters.

Pediatric Bone Is Different

The OR 1.98 for non-union applies to adult bone. Meta-analysis data (Choo 2021) shows pediatric long bone fractures don't carry the same non-union risk with NSAID use. The callus formation mechanism may compensate via alternative pathways in skeletally immature bone. This doesn't justify casual NSAID use in children's fractures, but it means the absolute contraindication framing is specific to adults.

The 65+ Paradox Has a Mechanistic Update

The Trappe 2011 data showed NSAIDs enhance muscle hypertrophy in older adults — assumed to be via systemic anti-inflammatory action. The 2025 Wang et al. mechanistic data (animal model) suggests the underlying cause is PGE2 depletion in aged muscle stem cells, not excess. This means the ultimate intervention may eventually be a localized PGE2 agonist delivered to the stem cell niche — not systemic NSAIDs. The clinical therapy doesn't exist yet, but the paradigm matters for understanding why the same drug does opposite things across ages.

Sources

Key References

Chuang et al., 2024 — Front Endocrinol Strong

Meta-analysis, N=523,240. Adult NSAID exposure: crude OR 1.98 for long bone non-union / delayed union. Pediatric OR 1.09 (non-significant).

Oh et al., 2018 — Am J Sports Med Strong

RCT: celecoxib vs ibuprofen vs tramadol post-rotator cuff repair. Celecoxib: significantly higher retear rates at 24 months. Non-selective NSAIDs: no significant difference from tramadol.

Lilja et al., 2018 — Acta Physiol Strong

RCT, N=31, young healthy adults. Ibuprofen 1200mg/day vs low-dose aspirin 75mg/day over 8 weeks. IBU group: significant blunting of strength and hypertrophy vs aspirin group.

Mackey et al., 2016 — FASEB J Strong

Ibuprofen 1200mg/day blunted satellite cell expansion via Notch pathway in young men following resistance exercise.

Trappe et al., 2011 — Am J Physiol Moderate

Clinical trial: ibuprofen 1200mg/day in adults 65+. Enhanced muscle protein synthesis and hypertrophy relative to control, via inflammaging reversal hypothesis.

Jones et al., 2020 — Cochrane Review Strong

20 RCTs, N=3305. Oral NSAIDs vs paracetamol for acute soft tissue injuries: equivalent pain relief at 1-7 days, slightly higher GI adverse event rate with NSAIDs.

Schug, 2021 — J Clin Med Moderate

Systematic review: short-term NSAID use (≤2 weeks) postoperatively does not clinically preclude bone fusion across spinal and appendicular surgeries.

Wang et al., 2025 — Cell Stem Cell Emerging

Animal model. Aged muscle stem cells are PGE2-depleted, not PGE2-flooded. Exogenous PGE2 via EP4 receptor agonism restores youthful regenerative capacity in aged muscle. Translational — no human therapy yet.

Dahners et al., 2004 — JAAOS

Foundational review: NSAIDs (especially COX-2 selective) diminish bone callus formation and increase spinal fusion non-union rates. Recommended NSAID avoidance when fracture or fusion healing is the goal.

The same drug that cuts your muscle gains in half at 30 can improve them at 65 — but it can double your fracture risk in either.

NSAIDs and Tissue HealingHelp or Hinder?

The COX-2 / PGE2 Pathway

Bone

Tendon-to-Bone

Muscle (Young Adults)

Muscle (65+ Adults)

Ligament

The "Inflammaging" Paradox

When to Use, When to Avoid

When NSAIDs Are Contraindicated

⚠ Refer / Advise Against

Older Advice vs Recent Evidence

Prophylactic NSAID Use in Athletes

NSAIDs After Rotator Cuff Repair

NSAIDs in the Elderly

Where the Research Falls Short

Limitation 1: Animal Dose Equivalency

Limitation 2: The Safe Short-Term Window

Limitation 3: Population Mismatch

Evidence-Based Recommendations

Tier 1 — Strong Evidence

Paracetamol for acute soft tissue injuries STRONG

AVOID NSAIDs in adult bone stress injuries STRONG

AVOID COX-2 inhibitors post-tendon-to-bone repair STRONG

Tier 2 — Moderate Evidence

Short-term non-selective NSAIDs for acute reactive tendinopathy MODERATE

NSAIDs for 65+ adults in resistance training programs MODERATE

Tier 3 — Emerging / Contextual

EP4 Receptor Agonism (Future) EMERGING

What Doesn't Work (Despite Common Practice)

NSAID Duration Rules by Tissue

Soft Tissue Sprain

Reactive Tendinopathy

Bone Stress Injury

Young Athlete in Training

Adults 65+ in RT Program

Post-Surgical Tendon

NSAID Weaning Criteria

What the Simple Answer Misses

Animal vs Human Evidence Gap

COX-2 Selectivity Is the Critical Variable for Tendon

Pediatric Bone Is Different

The 65+ Paradox Has a Mechanistic Update

Key References

Verdict Score

Get weekly evidence-based rehab verdicts

Want a coach, not just research?

Related free research

There are 424 more inside

NSAIDs and Tissue Healing
Help or Hinder?